ArticleUrology case reports2022

Efficacy of avelumab plus axitinib for advanced renal cell carcinoma as late-line therapy: A case report.

Ayano Uekawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.